Abstract

BackgroundThe influence of prosthesis-patient mismatch (PPM) on survival after aortic valve replacement (AVR) remains controversial. In this study, we sought to determine the effect of PPM on early (≤30 days) and late mortality (>30 days) after AVR or AVR combined with coronary artery bypass grafting (AVR with CABG).MethodsBetween January 1998 and March 2012, 2976 patients underwent AVR (n= 1718) or AVR with CABG (n=1258) at a single institution. PPM was defined as an indexed effective orifice area (EOAI) ≤0.85 cm2/m2 and patients were divided into two groups based on the existence of PPM. Cumulative probability values of survival were estimated with Kaplan-Meier method and compared between groups using Breslow test. Univariate and multivariate independent predictors of early mortality were identified using logistic regression. Cox proportional-hazard regression analysis was used to determine univariate and multivariate independent predictors of late mortality.ResultsEarly mortality was 6.7% in the PPM group vs 4.7% in the group with no PPM (p=0.013). Late mortality for the PPM group at 1, 5 and 10 years was 4%, 16% and 43%, respectively. Late mortality for the group with no PPM at 1, 5 and 10 years was 4%, 15% and 33% respectively. Independent predictors of early mortality included age, severely impaired left ventricular (LV) function, endocarditis, renal dysfunction, chronic obstructive pulmonary disease (COPD) and cardiopulmonary bypass (CPB) time. Multivariate independent predictors of late mortality included age, severely impaired LV function, diabetes, peripheral vascular disease (PVD), renal dysfunction, history of a cerebrovascular accident (CVA), CPB time and a history of previous cardiac surgery. PPM was not an independent predictor of early or late mortality.ConclusionPPM is not an independent predictor of both early and late mortality after AVR or AVR combined with CABG.

Highlights

  • The influence of prosthesis-patient mismatch (PPM) on survival after aortic valve replacement (AVR) remains controversial

  • Prosthesis-patient mismatch (PPM) after aortic valve replacement (AVR) occurs when the effective orifice area (EOA) of the implanted valve prosthesis is too small compared to the body surface area (BSA) of the patient [1]

  • Comparison of results is hampered by the fact that some authors use the published normal in vitro EOA values provided by the manufacturers to identify PPM [2,14,16], while others use the published normal in vivo EOA values to identify PPM [2,5,17]

Read more

Summary

Introduction

The influence of prosthesis-patient mismatch (PPM) on survival after aortic valve replacement (AVR) remains controversial. The EOAI is calculated by dividing the Several studies have shown that PPM is associated with increased early or late mortality after AVR [3,4,5,6]. Other studies contradict these findings and report that PPM does not have a significant impact on survival [7,8,9,10,11,12,13,14]. Comparison of results is hampered by differences in cut-off values for EAOI. Comparison of results is hampered by the fact that some authors use the published normal in vitro EOA values provided by the manufacturers to identify PPM [2,14,16], while others use the published normal in vivo EOA values to identify PPM [2,5,17]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call